Journal Article Review Ppublish 6 citations
PubMed: 35925072 DOI: 10.1007/s00108-022-01368-y
[The value of COVID-19 vaccination in the context of Long-COVID].
Inn Med (Heidelb) 63(8):840-850
Authors: Stilla Bauernfeind, Barbara Schmidt
Affiliations
- Abteilung für Krankenhaushygiene und Infektiologie, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland.
- Institut für Klinische Mikrobiologie und Hygiene, Universitätsklinikum Regensburg, Regensburg, Deutschland.
Abstract
There are currently no strategies available on how to deal with Long-COVID (COVID "coronavirus disease"). COVID-19 vaccination could be both a preemptive and a therapeutic option for the future. The evaluation of the available studies is complicated by varying definitions. There are, however, indications that (complete) COVID-19 vaccination is able not only to prevent symptomatic infection but also to reduce the risk of Long-COVID. In some patients with Long-COVID, symptoms are modified after (first and/or second) COVID-19 vaccination; however, there is no clear evidence for a real therapeutic effect on Long-COVID.
MeSH
Vaccines, Internal Medicine, Vaccination, Covid-19, Therapeutics, Post-Acute Covid-19 Syndrome
Cited by
- How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany. BMC Public Health, 2024
- A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition. Epidemiol Infect, 2023
- Exploring the Impact of COVID-19 on Physical Activity One Month after Infection and Its Potential Determinants: Re-Infections, Pre-Illness Vaccination Profiles/Types, and Beyond. Vaccines (Basel), 2023